At EuroMedLab 2025, we were joined by Nicole Selenko-Gebauer, Group Vice President and Chief Innovation Officer at Danaher Diagnostics, who shared her insights at what the future holds. In the two videos below, Selenko-Gebauer details Dahaher’s upcoming diagnostic priorities, addressing pressing needs in neurodegenerative disease diagnosis, and innovation in infectious disease monitoring.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

I have read and understand the Privacy Notice*

Subscribe